Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02805175
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
B14 | 1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'- DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)- QUINAZOLINE]-4'-AMINE | A,B | 3E7T | 0.76 | |
NCA | NICOTINAMIDE | A,B | 2E5D | 0.75 | |
NCA | NICOTINAMIDE | A,B,C,D | 2Z77 | 0.75 | |
NCA | NICOTINAMIDE | A,B | 1DMA | 0.75 | |
NCA | NICOTINAMIDE | A,B | 1ISM | 0.75 | |
NCA | NICOTINAMIDE | A,B | 1YC5 | 0.75 | |
NCA | NICOTINAMIDE | A | 2ZB7 | 0.75 | |
NCA | NICOTINAMIDE | A,B,C,D,E,F, G,H | 1R15 | 0.75 | |
NCA | NICOTINAMIDE | A,B | 2QQG | 0.75 | |
NCA | NICOTINAMIDE | A | 2OTV | 0.75 | |
NCA | NICOTINAMIDE | A | 2QHF | 0.75 | |
NCA | NICOTINAMIDE | A,B,C,D | 2C8A | 0.75 | |
NCA | NICOTINAMIDE | A,B | 2HJH | 0.75 | |
NCA | NICOTINAMIDE | A | 2A15 | 0.75 | |
NCA | NICOTINAMIDE | A | 2R6V | 0.75 | |
NCA | NICOTINAMIDE | A,B | 1ISI | 0.75 | |
NCA | NICOTINAMIDE | A,D,E | 2R9J | 0.75 | |
NCA | NICOTINAMIDE | A | 2H4J | 0.75 | |
NCA | NICOTINAMIDE | A,B | 2OD9 | 0.75 | |
NCA | NICOTINAMIDE | A,B,C,D,E | 1YC2 | 0.75 | |
NCA | NICOTINAMIDE | A,B | 3DZG | 0.75 | |
NCA | NICOTINAMIDE | A | 1OJU | 0.75 | |
8AP | N~3~-BENZYLPYRIDINE-2,3-DIAMINE | A | 2OHM | 0.7 | |
CNQ | 3-(4-CHLOROPHENYL)QUINOXALINE-5- CARBOXAMIDE | A,B,C,D | 1WOK | 0.7 | |
HM5 | 3-[(2,2-DIMETHYLPROPANOYL)AMINO]- N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE | A | 2NQ7 | 0.77 | |
3BA | 7-amino-2-tert-butyl-4-{[2-(1H- imidazol-4-yl)ethyl]amino}pyrido[2,3- d]pyrimidine-6-carboxamide | A | 3BAA | 0.72 | |
BC3 | 2-amino-7-(pyridin-3-ylmethyl)- 3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin- 4-one | A,B,C | 3DJF | 0.81 | |
9HX | 9-DEAZAHYPOXANTHINE | A,B,C | 1I80 | 0.81 | |
3AP | 3-AMINOPYRIDINE | A | 1AEF | 0.7 | |
ILT | MONOIMIDAZOLE LEXITROPSIN | A | 1LEY | 0.71 | |
ILT | MONOIMIDAZOLE LEXITROPSIN | B | 1LEX | 0.71 | |
CII | N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide | A | 2W0A | 0.71 | |
275 | 5-amino-1,2-dimethylpyridinium | X | 2RBW | 0.72 | |
C53 | 2-IMINO-5-(1-PYRIDIN-2-YL-METH- (E)-YLIDENE)-1,3-THIAZOLIDIN-4- ONE | A | 2V0D | 0.72 | |
P5C | 2-{[(1R,2S)-2-aminocyclohexyl]amino}- 4-[(3-methylphenyl)amino]pyrimidine- 5-carboxamide | A | 3FQE | 0.72 | |
BO2 | N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]- N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE | 2,H,K,N,V,Y | 2F16 | 0.71 | |
9DG | 9-DEAZAGUANINE | A,B,C,D,E | 1Q2S | 0.83 | |
9DG | 9-DEAZAGUANINE | A | 1IL4 | 0.83 | |
9DG | 9-DEAZAGUANINE | A,C | 1FSG | 0.83 | |
9DG | 9-DEAZAGUANINE | A,B,C,D | 1Q2R | 0.83 | |
DA1 | PYRIDINE-2,5-DIAMINE | A | 2AQD | 0.74 | |
STI | 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)- N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN- 2-YLAMINO)-PHENYL]-BENZAMIDE | A,B,C,D | 2HYY | 0.72 | |
STI | 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)- N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN- 2-YLAMINO)-PHENYL]-BENZAMIDE | A,B | 1IEP | 0.72 | |
STI | 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)- N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN- 2-YLAMINO)-PHENYL]-BENZAMIDE | A,B | 1OPJ | 0.72 | |
STI | 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)- N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN- 2-YLAMINO)-PHENYL]-BENZAMIDE | A | 1T46 | 0.72 | |
STI | 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)- N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN- 2-YLAMINO)-PHENYL]-BENZAMIDE | A | 3GVU | 0.72 | |
STI | 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)- N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN- 2-YLAMINO)-PHENYL]-BENZAMIDE | A | 2OIQ | 0.72 | |
STI | 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)- N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN- 2-YLAMINO)-PHENYL]-BENZAMIDE | A | 3FW1 | 0.72 | |
STI | 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)- N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN- 2-YLAMINO)-PHENYL]-BENZAMIDE | A | 2PL0 | 0.72 | |
STI | 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)- N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN- 2-YLAMINO)-PHENYL]-BENZAMIDE | A | 1XBB | 0.72 | |
NIL | Nilotinib | A,B,C,D | 3CS9 | 0.7 | |
NIL | Nilotinib | A | 3GP0 | 0.7 | |
I19 | N-(4-{[(3S)-3-(dimethylamino)pyrrolidin- 1-yl]carbonyl}phenyl)-5-fluoro- 4-[2-methyl-1-(1-methylethyl)-1H- imidazol-5-yl]pyrimidin-2-amine | A | 2W17 | 0.7 | |
OPN | {(2-AMINO-ETHYL)-[2-(2-OXO-1,2- DIHYDRO-[1,8]NAPHTHYRIDIN-3-YL)- ACETYL]-AMINO}-ACETIC ACID | A,B,C,D | 1HZS | 0.72 | |
PRC | N-[4-METHYL-3-[[4-(3-PYRIDINYL)- 2-PYRIMIDINYL]AMINO]PHENYL]-3-PYRIDINECARBOXAMIDE | A,B | 1FPU | 0.74 | |
C92 | N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)- 4-methyl-benzene-1,3-dicarboxamide | A,B | 3CPB | 0.72 | |
PD8 | PHOSPHORYLATED DIHYDROPTEROATE | A | 1W78 | 0.73 | |
34Q | (3R,4R)-4-(pyrrolidin-1-ylcarbonyl)- 1-(quinoxalin-2-ylcarbonyl)pyrrolidin- 3-amine | A | 2RIP | 0.73 | |
U05 | 6,11-DIHYDRO-11-ETHYL-6-METHYL- 9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN- 5-ONE | A | 1RTH | 0.71 | |
U05 | 6,11-DIHYDRO-11-ETHYL-6-METHYL- 9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN- 5-ONE | A | 1RT3 | 0.71 | |
U05 | 6,11-DIHYDRO-11-ETHYL-6-METHYL- 9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN- 5-ONE | A | 1LW2 | 0.71 | |
PB5 | N,N'-BIS(PYRIDIN-3-YLMETHYL)PYRIMIDINE- 4,6-DICARBOXAMIDE | A,B | 1XUR | 0.75 | |
QUI | 2-CARBOXYQUINOXALINE | A | 1PFE | 0.7 | |
QUI | 2-CARBOXYQUINOXALINE | A,B | 2DA8 | 0.7 | |
QUI | 2-CARBOXYQUINOXALINE | A,C,E,G | 2ADW | 0.7 | |
QUI | 2-CARBOXYQUINOXALINE | A | 1VS2 | 0.7 | |
QUI | 2-CARBOXYQUINOXALINE | A | 1XVN | 0.7 | |
QUI | 2-CARBOXYQUINOXALINE | A,B | 185D | 0.7 | |
QUI | 2-CARBOXYQUINOXALINE | A | 1XVK | 0.7 | |
QUI | 2-CARBOXYQUINOXALINE | A,C | 1XVR | 0.7 | |
QUI | 2-CARBOXYQUINOXALINE | A,B | 3GO3 | 0.7 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 2DHF | 0.72 | |
DZF | 5-DEAZAFOLIC ACID | A,B | 1DYH | 0.72 | |
DZF | 5-DEAZAFOLIC ACID | A,B,C,D | 1CDE | 0.72 | |
LQQ | 6-ACETYL-8-CYCLOPENTYL-5-METHYL- 2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3- D]PYRIMIDIN-7(8H)-ONE | A,B | 2EUF | 0.72 | |
DBQ | DEBROMOHYMENIALDISINE | A | 2C3J | 0.72 | |
DBQ | DEBROMOHYMENIALDISINE | A,B | 1U4D | 0.72 | |
DBQ | DEBROMOHYMENIALDISINE | A | 2CN8 | 0.72 | |
DBQ | DEBROMOHYMENIALDISINE | A | 1Z57 | 0.72 | |
CDB | 2-(6-CHLORO-3-{[2,2-DIFLUORO-2- (2-PYRIDINYL)ETHYL]AMINO}-2-OXO- 1(2H)-PYRAZINYL)-N-[(2-FLUORO-3- METHYL-6-PYRIDINYL)METHYL]ACETAMIDE | B,C | 1MU8 | 0.7 | |
MPZ | 4-[(4-METHYLPIPERAZIN-1-YL)METHYL]- N-{3-[(4-PYRIDIN-3-YLPYRIMIDIN- 2-YL)AMINO]PHENYL}BENZAMIDE | A | 1Y57 | 0.72 | |
HDU | N-[4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN- 3-YL)-2-PYRIMIDINYL]ACETAMIDE | A | 1OIQ | 0.71 | |
BPG | 9-(4-HYDROXYBUTYL)-N2-PHENYLGUANINE | A,B | 1QHI | 0.71 | |
IHZ | 5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine- 3-carboxamide | A | 3DKO | 0.72 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1S1X | 0.77 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWE | 0.77 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LW0 | 0.77 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 2HND | 0.77 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1FKP | 0.77 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1S1U | 0.77 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWF | 0.77 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 2HNY | 0.77 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1VRT | 0.77 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1LWC | 0.77 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1JLB | 0.77 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 3HVT | 0.77 | |
NVP | 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN- 6-ONE | A | 1JLF | 0.77 | |
553 | (7S)-2-(2-aminopyrimidin-4-yl)- 7-(2-fluoroethyl)-1,5,6,7-tetrahydro- 4H-pyrrolo[3,2-c]pyridin-4-one | A,B | 3DU8 | 0.71 | |
344 | 6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5- G]QUINAZOLIN-8-ONE | A | 2BBF | 0.7 | |
FOL | FOLIC ACID | A | 1PJ6 | 0.74 | |
FOL | FOLIC ACID | A,B | 1RD7 | 0.74 | |
FOL | FOLIC ACID | A,B | 1DHF | 0.74 | |
FOL | FOLIC ACID | A,B,C,D,E | 1QZF | 0.74 | |
FOL | FOLIC ACID | A | 4CD2 | 0.74 | |
FOL | FOLIC ACID | A | 1RX7 | 0.74 | |
FOL | FOLIC ACID | A | 1RX2 | 0.74 | |
FOL | FOLIC ACID | A | 1RX8 | 0.74 | |
FOL | FOLIC ACID | A | 1RA2 | 0.74 | |
FOL | FOLIC ACID | A,B | 1RE7 | 0.74 | |
FOL | FOLIC ACID | A | 7DFR | 0.74 | |
FOL | FOLIC ACID | A | 1VIF | 0.74 | |
FOL | FOLIC ACID | A,B | 1RB2 | 0.74 | |
FOL | FOLIC ACID | A | 1CD2 | 0.74 | |
FOL | FOLIC ACID | A | 2CD2 | 0.74 | |
FOL | FOLIC ACID | A,B | 1DYI | 0.74 | |
FOL | FOLIC ACID | A | 1DRF | 0.74 | |
FOL | FOLIC ACID | A,B,C,D | 3BMC | 0.74 | |
FOL | FOLIC ACID | A,B | 2D0K | 0.74 | |
FOL | FOLIC ACID | A | 1RA8 | 0.74 | |
CDA | 2-(6-CHLORO-3-{[2,2-DIFLUORO-2- (2-PYRIDINYL)ETHYL]AMINO}-2-OXO- 1(2H)-PYRAZINYL)-N-[(2-FLUORO-6- PYRIDINYL)METHYL]ACETAMIDE | B,C | 1MU6 | 0.74 | |
PB3 | N,N'-BIS(3-METHYLBENZYL)PYRIMIDINE- 4,6-DICARBOXAMIDE | A,B | 1XUC | 0.7 | |
HM4 | TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN- 3-YL}CARBAMATE | A | 2NQ6 | 0.74 |